- Home
- TSSI vs OCGN Comparison
TSSI vs OCGN Comparison
Compare TSSI & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSSI
- OCGN
- Stock Information
- Founded
- TSSI 2004
- OCGN 2013
- Country
- TSSI United States
- OCGN United States
- Employees
- TSSI N/A
- OCGN N/A
- Industry
- TSSI Professional Services
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSSI Consumer Discretionary
- OCGN Health Care
- Exchange
- TSSI Nasdaq
- OCGN Nasdaq
- Market Cap
- TSSI 221.9M
- OCGN 205.2M
- IPO Year
- TSSI N/A
- OCGN N/A
- Fundamental
- Price
- TSSI $14.44
- OCGN $0.83
- Analyst Decision
- TSSI
- OCGN Strong Buy
- Analyst Count
- TSSI 0
- OCGN 3
- Target Price
- TSSI N/A
- OCGN $6.00
- AVG Volume (30 Days)
- TSSI 3.5M
- OCGN 4.8M
- Earning Date
- TSSI 05-15-2025
- OCGN 05-09-2025
- Dividend Yield
- TSSI N/A
- OCGN N/A
- EPS Growth
- TSSI 770.13
- OCGN N/A
- EPS
- TSSI 0.35
- OCGN N/A
- Revenue
- TSSI $231,211,000.00
- OCGN $4,522,000.00
- Revenue This Year
- TSSI N/A
- OCGN N/A
- Revenue Next Year
- TSSI N/A
- OCGN N/A
- P/E Ratio
- TSSI $41.14
- OCGN N/A
- Revenue Growth
- TSSI 262.87
- OCGN N/A
- 52 Week Low
- TSSI $1.48
- OCGN $0.52
- 52 Week High
- TSSI $18.26
- OCGN $1.98
- Technical
- Relative Strength Index (RSI)
- TSSI N/A
- OCGN 56.73
- Support Level
- TSSI N/A
- OCGN $0.64
- Resistance Level
- TSSI N/A
- OCGN $0.81
- Average True Range (ATR)
- TSSI 0.00
- OCGN 0.08
- MACD
- TSSI 0.00
- OCGN 0.01
- Stochastic Oscillator
- TSSI 0.00
- OCGN 53.00
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").